QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=F814328285108F7A4EA0DA28CFE696D7;jsessionid=502E776C630F24248151AAEED05D5B46;jsessionid=FE390919606FA9CDF00B0C61A4202833;jsessionid=12E26BE49F608DA880933580566077C6;jsessionid=2333D5F98CAB448A7222F81C5FB26A40;jsessionid=5AB2CF6117C325B272C7E80AEB675143;jsessionid=1CFBE6987AE3F7A9B02B4AB9D0F9BF09;jsessionid=08AAB5852B10E152D33F25BC154E6033 (gene)

1. Ataxin-2 sequesters Raptor into aggregates and impairs cellular mTORC1 signaling.
2. ATXN2 is a target of N-terminal proteolysis.
3. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
4. TDP-43 impairs sleep in Drosophila through Ataxin-2-dependent metabolic disturbance.
5. Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggre…

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=F814328285108F7A4EA0DA28CFE696D7;jsessionid=502E776C630F24248151AAEED05D5B46;jsessionid=FE390919606FA9CDF00B0C61A4202833;jsessionid=12E26BE49F608DA880933580566077C6;jsessionid=2333D5F98CAB448A7222F81C5FB26A40;jsessionid=5AB2CF6117C325B272C7E80AEB675143;jsessionid=1CFBE6987AE3F7A9B02B4AB9D0F9BF09;jsessionid=08AAB5852B10E152D33F25BC154E6033